Summary
The case histories of 72 subsequently treated patients — 44 with acute leukemia, 10 with chronic myeloid leukemia, 16 with severe aplastic anemia and 2 with neuroblastoma — were analyzed after bone marrow transplantation (BMT) with respect to pulmonary diseases. Thirty-eight patients suffered from a total of 51 pulmonary complications, which led to death in 20. Of 13 patients, 3 died of bacterial pneumonia, all of them during granulocytopenia; 2 of 6 patients died of fungal pneumonia and 2 out of 3 of a mixed bacterialmycotic infection. Adult respiratory distress syndrome (ARDS) led to death in 2 patients. A granulocyte count under 500/µl correlated significantly (P<0.002) with the fatal outcome of bacterial, fungal and ARDS pneumonia as well as with bronchitis. Viral pneumonia led to death in 8 of 9 patients; in each there was a significant correlation (P<0.05) with graft-versus-host disease (GvHD). Patients with repeated episodes of pulmonary illness had significantly more chronic GvHD (P<0.05); several of these patients displayed a reduction in helper T cells and an increase in suppressor T cells in the peripheral blood. The natural killer (NK) cells were reduced and the percentage of activated NK cell level lay between 6% and 69%. B-cells were absent or deficient. These findings explain in part the absence of specific antibody reactivity. Five of these patients also contracted GvHD-associated obstructive bronchiolitis, which did not respond to therapy. Pulmonary infiltrates of unknown origin (including idiopathic interstitial pneumonia) occurred in 8 of the patients (11.1%), with a fatal outcome in 3 patients. Significant changes (P<0.05) in lung function after BMT appeared in the form of reduced vital capacity (VC) increased residual volume (RV) and an increase in RV expressed as the percentage of total lung capacity. Pulmonary diseases were the most common complication and cause of death in our patients after BMT.
Article PDF
Similar content being viewed by others
Abbreviations
- AEL:
-
acute erythroid leukemia
- AHTCG:
-
anti-human T-cell globulin
- ALL:
-
acute lymphoblastic leukemia
- AML:
-
acute myeloid leukemia
- ARDS:
-
adult respiratory distress syndrome
- AUL:
-
acute undifferentiated leukemia
- BMT:
-
bone marrow transplantation
- CR:
-
complete remission
- CML:
-
chronic myeloid leukemia
- CMV:
-
cytomegalovirus
- Ext.:
-
extensive
- GvHD:
-
graft versus host disease
- Lim.:
-
limited
- PR:
-
partial remission
- Rel.:
-
relapse
- SAA:
-
severe aplastic anemia
- VZV:
-
varicella zoster virus.Lung function tests
- DLCO:
-
single-breath CO-diffusion capacity
- FEV1 :
-
forced expiratory volume in 1 s
- KCO:
-
Krogh's constant
- MBC:
-
maximal breathing capacity
- RAW:
-
airway resistance
- RV:
-
residual volume
- SRAW:
-
specific airway resistance
- TGV:
-
thoracic gas volume
- TLC:
-
total lung capacity
- VC:
-
vital capacity
References
Appelbaum FR, Meyers JD, Fefer A, Flournoy N, Cheever MA, Greenberg PD, Hackman R, Thomas ED (1982) Non-bacterial nonfungal pneumonia following marrow transplantation in 100 identical twins. Transplantation 33:265–268
Atkinson K, Storb R, Prentice RL, Weiden TL, Witherspoon RP, Sullivan K, Noel D, Thomas ED (1979) Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 4:720–731
Atkinson K, Hansen JA, Storb R, Goehle S, Goldstein G, Thomas ED (1982) T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets. Blood 59:1292–1298
Atkinson K, Farewell V, Storb R, Tsoi MS, Sullivan KM, Witherspoon RP, Fefer A, Clift R, Goodell B, Thomas ED (1982) Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 60:714–720
Atkinson K, Bryant D, Biggs J, Concannon A, Dodds A (1984) Obstructive airways disease: a rare but serious manifestation of chronic graft-versus-host disease after allogeneic marrow transplantation in humans. Transplant Proc 16:1030–1033
Barrett A (1982) Total body irradiation (TBI) before bone marrow transplantation in leukemia — a cooperative study from the European Group for Bone Marrow Transplantation. Br J Radiol 55:562–567
Barrett A, Depledge MH, Powles RL (1983) Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation. Int J Radiat Oncol Biol Phys 9:1029–1034
Beschorner WE, Saral R, Hutchins GM, Tutschka PJ, Santos GW (1978) Lymphocytic bronchitis associated with graft versus host disease in recipients of bone marrow transplants. N Engl J Med 299:1030–1036
Beschorner WE, Hutchins GM, Burns W, Saral R, Tutschka PJ, Santos GW (1980) Cytomegalovirus pneumonia in bone marrow transplant recipients: miliary and diffuse patterns. Am Rev Respir Dis 122:107–114
Blume KG, Beutler E, Bross KJ, Chillar RK, Ellington OB, Fahey JL, Farbstein MJ, Forman SJ, Schmidt GM, Scott EP, Spruce WE, Turner MA, Wolf JL (1980) Bonemarrow ablation and allogeneic marrow transplantation in acute leukemia. N Engl J Med 302:1041–1046
Bortin MM, Kay HEM, Gale RP, Rimm AA (1982) Factors associated with interstitial pneumonitis following bone marrow transplantation for acute leukaemia. Lancet I:437–439
Bortin MM, Gale RP, Kay HEM, Rimm AA (1983) Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality. JAMA 249:1166–1175
Bradstock KF, Coles R, Despas R, Tivver K, Koutts J, Hoghes WG (1984) Fatal obstructive airways disease after bone marrow transplantation. Transplant Proc 16:1034–1036
Braude S, Krausz T, Apperley J, Goldman JM, Royston D (1985) Adult respiratory distress syndrome after allogeneic bone-marrow transplantation: evidence for a neutrophil-independent mechanism. Lancet I:1239–1242
Buckner CD, Clift RA, Sanders JE, Meyers JD, Counts GW, Vernon VT, Thomas ED (1978) Protective environment for marrow transplant recipients. Ann Intern Med 89:893–901
Buckner CD, Clift RA, Thomas ED, Hersman J, Sanders JE, Stewart PS, Wade JC, Murphy M, Counts G, Meyers JD (1983) Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures. Infection 11:243–250
Buckner CD, Meyers JD, Springmeyer SC, Sullivan KM, Hackman RC, Flournoy N, Clift R, Storb R, Witherspoon RP, Petersen FB, Thomas ED (1984) Pulmonary complications of marrow transplantation. Review of the Seattle experience. Exp Hematol [Suppl 15] 12:1–5
Collis CH (1980) Lung damage from cytotoxic drugs. Cancer Chemother Pharmacol 4:17–27
Condie RM, O'Reilly RJ (1984) Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. A randomized trial in bone marrow transplant recipients. Am J Med 76:134–141
Depledge MH, Barrett A, Powles RL (1983) Lung function after bone marrow grafting. Int J Radiat Oncol Biol Phys 9:145–151
Editorial (1984) Graft versus host disease after marrow transplantation. Lancet I:491–492
Favrot M, Tidman JN, Blacklock H, Lopez E, Bofill M, Lampert I, Morgenstein G, Powels R, Prentice HG, Hoffbrand AV (1983) T cell regeneration after allogenic bone marrow transplantation. Clin Exp Immunol 54:59–72
Friedrich W, O'Reilly RJ, Koziner B, Gebhard DF, Good RA, Evans RL (1982) T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GvHD: imbalances of T-cell subpopulations having unique regulatory and cognitive functions. Blood 59:696–701
Gale RP, Champlin RE (1984) How does bone-marrow transplantation cure leukemia? Lancet II:28–29
Gluckman E, Lotsberg J, Devergie A, Zhao M, Melo R, Gomez-Morales M, Nebout T, Mazeron MC, Perol Y (1983) Prophylaxis of herpes infection after bone-marrow transplantation by oral Acyclovir. Lancet II:706–708
Goolden AWG, Goldman JM, Kam KC, Dunn PA, Baughan ASJ, McCarthy DM, Worsley AM, Gordon Smith EC, Samson D, Catovsky D, Galton DAG (1983) Fractionation of whole body irradiation before bone marrow transplantation for patients with leukemia. Br J Radiol 56:245–250
Gratama JW, Naipal A, Oljans P, Zwaan FE, Verdonck LF, Witte de T, Vossen JMJJ, Bolhuis RLH, de Gast GC (1984) T lymphocyte repopulation and differentiation after bone marrow transplantation. Early shifts in the ratio between T4+ and T8+ T lymphocytes correlate with the occurrence of acute graft versus host disease. Blood 63:1416–1423
Hersman J, Meyers JD, Thomas ED, Buckner CD, Clift R (1982) The effect of granulocyte transfusion on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med 96:149–152
Johnson FL, Stokes DC, Ruggiero M, Dallapozza L, Callihan TR (1984) Chronic obstructive airways disease after bone marrow transplantation. J Pediatr 105:370–376
Jordan MC (1983) Latent infection and the elusive cytomegalovirus. Rev Infect Dis 5:205–215
Karp DD, Ervin TJ, Tuttle S, Gorgone BC, Lavin P, Yunis EJ (1982) Pulmonary complications during granulocyte transfusions: incidence and clinical features. Vox Sang 42:57–61
Keane TJ, van Dyk J, Rider WD (1981) Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation. Int J Radiat Oncol Biol Phys 7:1365–1370
Kirchner H (1983) Immunobiology of infection with human cytomegalovirus. Adv Cancer Res 40:31–105
Kubanek B, Ernst P, Schäfer U, Ostendorf P, Wolf H (1984) A controlled trial of intravenous hyperimmunoglobulin in the prevention of cytomegalovirus infection in bone marrow transplant recipients. Exp Hematol [Suppl 15] 12:111–112
Kubanek B, Ernst P, Ostendorf P, Schäfer U, Wolf H (1985) Preliminary data of a controlled trial of intravenous hyperimmune globulin in the prevention of cytomegalovirus infection in bone marrow transplant recipients. Transplant Proc 17:468–469
Kurzrock R, Zander A, Kanojia M, Vellekoop L, Spitzer G, Jaganath S, Schell S, Peters L, Dicke K (1984) Obstructive lung disease after allogeneic bone marrow transplantation. Transplantation 37:156–160
Link H, Reinhard U, Niethammer D, Krüger GRF, Waller HD, Wilms K (1982) Obstructive ventilation disorder as a severe complication of chronic graft versus host disease after bone marrow transplantation. Exp Hematol [Suppl 10] 10:92–93
Medoff G, Kobayashi GS (1980) Strategies in the treatment of systemic fungal infections. N Engl J Med 302:145–155
Meyers JD, Flournoy N, Thomas ED (1980) Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. J Infect Dis 142:816–824
Meyers JD, Flournoy N, Thomas ED (1982) Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis 4:1119–1131
Meyers JD, McGuffin RW, Bryson YJ, Cantell K, Thomas ED (1982) Treatment of cytomegalovirus pneumonia after marrow transplant with combined Vidarabine and human leukocyte interferon. J Infect Dis 146:80–84
Meyers JD, Leszczynski J, Zaia JA, Flournoy N, Newton B, Snydman DR, Wright GG, Levin MJ, Thomas ED (1983) Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med 98:442–446
Neiman PE, Reeves W, Ray G, Flournoy N, Lerner KG, Sale GE, Thomas ED (1977) A prospective analysis of interstitial pneumonia and opportunistic viral infections among recipients of allogeneic BM grafts. J Infect Dis 136:754–767
O'Brien KD, Hackman RC, Sale GE, Prentice R, Deeg J, Thomas ED, Storb R (1984) Lymphocytic bronchitis unrelated to acute graft-versus-host disease in canine marrow graft recipients. Transplantation 37:233–238
Pizzo PA, Commers J, Cotton D, Gress J, Hathorn J, Hiemenz J, Longo D, Marshall D, Robichaud KJ (1984) Approaching the controversies in antibacterial management of cancer patients. Am J Med 76:436–449
Quinnan GV, Kirmani N, Rook AH, Manischewitz JF, Jackson L, Moreschi G, Santos GW, Saral R, Burns WH (1982) Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone marrow-transplant recipients. N Engl J Med 307:7–13
Ralph, DD, Springmeyer SC, Sullivan KM, Hackman RC, Storb R (1984) Rapidly progressive air-flow obstruction in marrow transplant recipients — possible association between obliterative bronchiolitis and chronic graft-versus-host disease. Am Rev Respir Dis 129:641–644
Rinaldo JE, Rogers RM (1982) Adult respiratory-distress syndrome. Changing concepts of lung injury and repair. N Engl J Med 306:900–909
Ringden O, Baryd I, Johansson B, Gahrton G, Groth CG, Lundgren G, Lonnovist B (1983) Increased mortality by septicemia, interstitial pneumonitis and pulmonary fibrosis among bone marrow transplant recipients receiving an increased mean dose of total irradiation. Acta Radiol Oncol Rad Phys B 22:423–428
Roca J, Granena A, Rodriguez-Roisin R, Alvarez P, Agusti-Vidal A (1982) Fatal airway disease in an adult with chronic graft versus host disease. Thorax 37:77–78
Rodt H, Kolb HJ, Netzel B, Haas RJ, Wilms K, Bender-Götze C, Link H, Thierfelder S (1981) Effect of anti-T-cell globulin on GvHD in leukemic patients treated with BMT. Transplant Proc 13:257–261
Rühle KH, Matthys H (1976) Kritische Auswahl von Sollwerten für ein Computer-Programm zur Routine-Lungenfunktionsdiagnostik. Pneumologie 153:223–233
Schroff RW, Gale RP, Fahey JL (1982) Regeneration of T cell subpopulations after bone marrow transplantation: cytomegalovirus infection and lymphoid subset imbalance. J Immunol 129:1926–1930
Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman T, Tsoi MS, Storb R, Thomas ED (1980) Chronic graft versus host syndrome in man, a long-term clinicopathologic study of 20 Seattle patients. Am J Med 69:204–212
Serota FT, August CS, Koch PA, Fox W, D'Angio GJ (1984) Pulmonary function in patients undergoing bone marrow transplantation. Med Pediatr Oncol 12:137–143
Shank B, Chu FCH, Dinsmore R, Kapoor N, Kirkpatrick D, Teitelbaum H, Reid A, Bonfiglio P, Simpson L, O'Reilly RJ (1983) Hyperfractionated total body irradiation for bone marrow transplantation: results in seventy leukemia patients with allogeneic transplantation. Int J Radiat Oncol Biol Phys 9:1607–1612
Sloane JP, Depledge MH, Powels RL, Morgenstern GR, Trickey BS, Dady PJ (1983) Histopathology of the lung after bone marrow transplantation. J Clin Pathol 36:546–554
Sørensen PG, Ernst P, Panduro J, Møller J (1984) Reduced lung function in leukemia patients undergoing bone marrow transplantation. Scand J Haematol 32:253–257
Springmeyer SC, Kopecky KJ, Deeg J, Whitehead J, Altman LC, Storb R (1984) Pulmonary bronchoalveolar cell and protein kinetics in dogs given total-body irradiation, autologous marrow grafts, and Methotrexate. Transplantation 37:336–339
Storb R, Prentice RL, Buckner CD, Clift RA, Appelbaum F, Deeg J, Doney K, Hansen JA, Mason M, Sanders JE, Singer J, Sullivan KM, Witherspoon RP, Thomas ED (1983) Graft-versus host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. N Engl J Med 308:302–307
Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD (1975) Bone-marrow transplantation (first of two parts). N Engl J Med 292:832–843
Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournay N, Goodell BW, Hickman RO, Lerner KG, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weidel PL (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49:511–533
Torres J, Bross D, Lam W, Wharam M, Santos G, Order S (1982) Risk factors in interstitial pneumonitis following allogeneic bone marrow transplantation. Int J Radiat Oncol Biol Phys 8:1301
Verdonck LF, de Gast GC (1984) Is cytomegalovirus infection a major cause of T cell alterations after (autologous) bone-marrow transplantation? Lancet I:932–935
Vitale V, Bacigalupo A, van Lint MT, Frassoni F, Ricci G, Siracusa G, Marziano G, Vitali ML, Scielzo, Tomassini A, Bistolfianda F, Marmont AM (1983) Fractionated total body irradiation in marrow transplantation for leukaemia. Br J Haematol 55:547–554
Wade JC, McGuffin RW, Springmeyer SC, Newton B, Singer JW, Meyers JC (1983) Treatment of cytomegalovirus pneumonia with high-dose-Acyclovir and human leukocyte interferon. J Infect Dis 148:557–562
Watson JG (1983) Problems of infection after bone marrow transplantation. J Clin Pathol 36:683–692
Welte K, Ciobanu N, Moore MAS, Gulati S, O'Reilly RJ, Mertelsmann R (1984) Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin-2. Blood 64:380–385
Wernet P, Ostendorf P, Sigg M, Muller CP, Uchanska-Ziegler B, Waller HD et al. (1986) Sequential expression of MHC class II allo-antigens for HLA-DP, DR and DQ on the surface of leukemic blast cells apparently correlating with lineage independent differentiation states. Leuk Res (in press)
Wilms K, Link H, Meyer P, Ostendorf P, Schüch K, Waller HD, Wernet P, Niethammer D, Dopfer R, Schneider W, Schunter F, Breitling G, Frommhold W, Seeger G, Voss AC (1982) Knochenmarktransplantation bei Patienten mit Leukämien. Klin Wochenschr 60:1279–1287
Winston DJ (1982) Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann Intern Med 97:11–18
Winston DJ, Gale RP, Meyer DV, Young LS (1979) Infectious complications of human bone marrow transplantation. Medicine 58:1–31
Winston DJ, Territo MC, Ho WG, Miller MJ, Gale RP, Golde DW (1982) Alveolar macrophage dysfunction in human bone marrow transplant recipients. Am J Med 73:859–866
Winston DJ, Ho WG, Champlin RE, Gale RP (1984) Infectious complications of bone marrow transplantation. Exp Hematol 12:205–215
Winston DJ, Ho WG, Lin CH, Budinger MD, Champlin RE, Gale RP (1984) Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation Preliminary results of a controlled trial. Am J Med 76:128–133
Witherspoon RP, Storb R, Ochs HD, Flournoy N, Kopecky KJ, Sullivan KM, Deeg HJ, Sosa R, Noel DR, Atkinson K, Thomas ED (1981) Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment Blood 58:360–368
Zwaan FE, Hermans J, Barrett AJ, Speck B (1984) Bone marrow transplantation for acute nonlymphoblastic leukemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.) Br J Haematol 56:645–654
Author information
Authors and Affiliations
Additional information
Supported in part by SFB 120, A2, B1, C1, F2
Rights and permissions
About this article
Cite this article
Link, H., Reinhard, U., Walter, E. et al. Lung diseases after bone marrow transplantation. Klin Wochenschr 64, 595–614 (1986). https://doi.org/10.1007/BF01735262
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01735262